Fortress Biotech, Inc.

FBIONASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
3.07 USD
↗ 0.14 (4.78%)AT CLOSE (11:59 AM EDT)
3.09
↗ 0.02 (0.49%)
POST MARKET (AS OF 07:38 PM EDT)
Post Market
AS OF 07:38 PM EDT
3.09
↗ 0.02 (0.49%)
🔴Market: CLOSED

Fortress Biotech, Inc. (FBIO) trades at $3.06 per share. Our models show a "Strong Buy" technical signal alongside a "Neutral" fundamental rating. This is driven by a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (73.5%) and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest FBIO is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Jun 17, 2026.

Open?$2.97
High?$3.15
Low?$2.94
Prev. Close?$2.93
Volume?689.4K
Avg. Volume?442.3K
VWAP?$3.07
Rel. Volume?1.56x
Bid / Ask
Bid?$3.05 × 7.0K
Ask?$3.14 × 100
Spread?$0.09
Midpoint?$3.09
Valuation & Ratios
Market Cap?102.0M
Shares Out?N/A
Float?24.5M
Float %?78.9%
P/E Ratio?0.86
P/B Ratio?0.63
EPS?$3.59
Dividend?0.49%
Ex-Dividend?N/A
News
Profile
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.
Themes
Biotech - Drug Development›Clinical-Stage Platforms
Employees
78
Market Cap
97.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.fortressbiotech.com
Listed
2011-11-17
Address
1111 KANE CONCOURSE
BAY HARBOR ISLANDS, FL 33154
Phone: 781-652-4500
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
60
Z-Score?
0
Momentum?
79
Short Sent.?
39
Piotroski F-Score?5/9Mixed
Altman Z-Score?-1.74Distress
Confidence?47%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?20.79%Squeeze Risk
Short Interest?5.1M
Days to Cover?11.3
Free Float24.5M
Avg Daily Volume450.0K
Settlement Date2026-05-29
Financial Health
Current Ratio?2.86Strong
Quick Ratio?2.77Strong
Cash Ratio?2.47Strong
Debt/Equity?0.24Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
0.9CHEAP▾
P/B?
Peers
100
S&P
97
0.63CHEAP▾
P/S?
Peers
100
S&P
78
1.51CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
2.3CHEAP▾
EV/Sales?
S&P
97
-1.70CHEAP▾
Returns & Efficiency
ROE?
Peers
50
S&P
95
73.5%STRONG▾
ROA?
Peers
50
S&P
97
33.4%STRONG▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$-114480449
Fundamentals ratios updated end of day
MarketsMoversWatchlist